Pain. acute pain
Conditions
Interventions
Intervention 1: 30 mL bupivacaine 0.5% with 3 mL of isotonic saline chloride. Intervention 2: 30 mL bupivacaine 0.5% with 2 mL (100 µg) of fentanyl and 1 mL of isotonic saline chloride. Intervention 3
Treatment - Drugs
30 mL bupivacaine 0.5% with 3 mL of isotonic saline chloride
30 mL bupivacaine 0.5% with 2 mL (100 µg) of fentanyl and 1 mL of isotonic saline chloride
30 mL bupivacaine 0.5%with 2 mL isotonic saline chloride and 100ng (1 mL) naloxone
30 mL bupivacaine 0.5%with 2 mL(100 µg) of fentanyl and 100 ng (1 mL) naloxone
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Patients with American Society of Anesthesiologists physical status class I and II. Exclusion Criteria: Hepatic or Renal failure; Heart diseases; history of drug allergy; substance abuse (including opioids and benzodiazepines); morbid obesity; history of postoperative nausea and vomiting (PONV); history of motion sickness; smokers.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensory block Onset time and duration. Timepoint: Every 5 minutes from supraclavicular block. Method of measurement: measurement of time.;Motor block onset and duration time. Timepoint: Time from supraclavicular block, every 5 minutes. Method of measurement: measurement of time. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pruritus. Timepoint: Time from supraclavicular block, every 5 minutes. Method of measurement: measurement of time. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Movafegh
Dr. Shariati Hospital
Outcome results
None listed